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The Hyponatremia epidemic: 
A Frontier Too Far?
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Therapeutics, University of Aberdeen, Aberdeen, UK
Hyponatremia is the most common electrolyte abnormality and is often neglected, espe-
cially in elderly and seemingly terminal patients. Hyponatremia can be asymptomatic 
or can cause symptoms ranging from nausea and lethargy to convulsions and coma. 
This condition has become increasingly common over time with a similar time course 
to the increase in adoption of low salt diets. The popularization of low salt may not be 
justified in people with normal kidney function in whom the compatible statistically based 
evidence that salt causes hypertension has been challenged by experimental evidence 
to the contrary.
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KeY POiNTS
 1. Hyponatremia is the most common electrolyte abnormality and is often neglected, especially in 
elderly and seemingly terminal patients.
 2. Hyponatremia can be asymptomatic or can cause symptoms ranging from nausea and lethargy 
to convulsions and coma.
 3. The increase in prevalence over time has a similar time course to the increase in adoption of 
low-salt diets.
 4. Investigation into the electrolyte status of individual subjects would be expected to reveal the 
suitability or otherwise of dietary salt intake.
 5. If policy 4 above is adopted, it may be necessary to withdraw recommendation of low-salt diet to 
the entire population.
 6. Investigation into the electrolyte status of individual subjects would also be advisable in view of 
the lack of experimental evidence in normal people that high salt raises blood pressure and that 
hypertensive patients have normal body sodium.
HYPONATReMiA
A normal concentration of sodium ions (Na+) in plasma and extracellular fluid is essential for nerve 
and muscle electrical conduction (1, 2). If dietary salt intake does not equal or exceed salt loss in 
urine and sweat, a fall in Na+ below concentrations that allow normal function will occur (2). This 
condition (hyponatremia) causes dysfunction of brain and body; much Alzheimer’s disease has been 
attributed to hyponatremia (3). In a hot country, such as Uganda, in which there is a high sweating 
rate that loses salt, the prevalence of hyponatremia in hospitalized patients over the age of 60 was as 
high as 25% (4). Hyponatremia is also associated with diuretic treatment (5, 6).
The prevalence of hyponatremia should highlight the magnitude of the problem and should 
prompt health-care professionals to investigate and treat these patients and terminate low salt diet if 
being adopted by elderly and chronic sick individuals to their detriment. Low salt diet is associated 
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with increased mortality and has been heavily criticized in the US 
press and the Lancet (7). As long as sodium excretion is normal, 
a high salt diet is safe; if such excretion is excessive, as is often the 
case in the elderly, low salt diet is very dangerous. In subjects with 
normal or increase Na+ excretion, an increase salt intake could 
improve the quality of life.
Squecco et al. (8) have recently reported detrimental effects 
of hyponatremia on two different neuronal cell lines, SK-N-AS 
and SH-SY5Y, independent of osmotic alterations. They made 
experiments in low sodium medium either in hypo-, hyper-, or 
iso-osmotic conditions, for a short (24 h) or long time (7 days). 
Their results indicate that cell capacitance and membrane 
conductance increase regardless of osmolarity, but such effects 
are differently dependent on time in culture. Relevant to the 
mechanisms involved in maintenance of cell capacitance and 
membrane conductance in hyper-osmotic medium, they also 
observed a greater contribution of the sodium–calcium exchanger 
with respect to hypo-osmotic medium and control. In view of 
these fundamental changes in basic neuronal electrophysiology 
induced by hyponatremia, and the basic fact that depolarization 
is a sodium-dependent function in electrically active cells, e.g., 
heart, vascular smooth muscle, and skeletal muscle, we can only 
emphasize the need to avoid hyponatremia at all cost.
THe iNCReASiNG PRevALeNCe
There are an increasing number of reports of the rising prevalence 
of hyponatremia, e.g., Nair et al. (9), Lobo-Rodríguez et al. (10), 
and Gandhi et al. (11) even in children (who surely should not be 
given a low salt diet) (12), including neonates (13) and athletes 
who drink too much water when losing salt through sweating 
(14, 15). Pituitary deficiency of ACTH (16), subarachnoid hem-
orrhage (17), osteoporosis, failure of salt supplementation with 
medical treatments (18), thiazide treatment in the elderly (19), 
and thiazide and psychotropic drugs combined (20) have all been 
associated with severe hyponatremia. When these conditions 
occur in a population on low salt intake, a considerable possible 
risk may result in unnecessary morbidity, mortality, and strain 
on health services.
THe STATe ADviCe TO POPULATiONS TO 
ADOPT THe LOw SALT DieT, i.e., 
SHOULD NORMAL PeOPLe eAT A LOw 
SALT DieT?
Many states advise their populace to eat a low salt diet, an advice 
that is based on the many studies, indicating that this will save 
lives (21–27). We protest about the spurious argument that salt 
intake has increased in recent times (28). The historical evidence 
is quite opposite, as early civilizations, the Navy, and housewives 
have until recently used salt for preserving food. The most pre-
cious gift a guest could offer his host in previous civilizations was 
“bread and salt.” Now, with food being preserved in freezers, salt 
intake has decreased. The debate continues (28, 29).
Meta-analyses of trials in normotensive subjects are similar to 
prospective studies in estimating a 1.7 mmHg rise per 100-mM 
increment in urinary 24-h sodium excretion, but prospective 
studies relating health outcomes to 24-h sodium excretion 
produced inconsistent results (30–32). The fall in BP with salt 
restriction may be greater in patients with diabetic kidney disease 
than in normals (33). In a very large study in European White eth-
nic subjects, in whom sodium intake was accurately assessed by 
measuring 24-h urinary sodium output, no correlation between 
salt intake and blood pressure was shown (34), suggesting that 
the earlier studies on mixed ethnic populations were unsound, 
as salt sensitivity varies in various populations (2). When normal 
people with normal renal function ingest sodium, any excess is 
excreted in the urine, and total body sodium remains normal 
(35). The issue of whether nations should be on low salt could 
be decided by a double-blind controlled clinical trial of similar 
groups of normal people randomized to low-salt versus high-salt 
diet and followed up for a lifetime. The end points would be age at 
death, clinical hypertension confirmed by automated 24-h blood 
pressure monitoring, and plasma sodium ion concentration.
In view of the personal and economic burden on health pro-
vision of hyponatremia, a wiser policy in the meantime might 
be for any normotensive person wondering whether to restrict 
their salt intake to undergo renal function tests and a salt loading 
test. If there is no contraindication, a normal salt diet could be 
prescribed with the proviso that the tests be repeated if the patient 
develops hypertension confirmed by automated 24-h blood pres-
sure monitoring.
DiReCT eXPeRiMeNTAL eviDeNCe 
PeRTAiNiNG TO SALT iNGeSTiON AND 
BODY SODiUM
Salt Loading
We (36) made a statistical analysis of the salt loading study of Luft 
et al. (37). The relationship, of systolic BP to salt loading of 7 days, 
in that study showed no significance (Spearman rank correlation), 
until doses of over 50 g/day (Caucasian subjects, n = 7). The other 
group of Afro-Caribbean subjects (n = 7) started to show a small 
increase in BP at 20 g/day, showing that ethnicity is important. 
Studies with longer periods of salt-loading and more subjects 
[4 weeks (38), 9 weeks (39)] found no increase in BP in normo-
tensive and hypertensive subjects, respectively. Experimentally, 
high salt ingestion has no effect on blood pressure in 9 weeks, but 
there remains the possibility that salt loading for longer durations 
might cause a rise in BP.
Total exchangeable Sodium
The Medical Research Council Blood Pressure Group in Glasgow 
measured total exchangeable sodium in normals, patients 
developing hypertension and patients with established hyperten-
sion (40). There were no differences between the three groups. 
Hypertension is not associated with increased body sodium.
Dietary Salt Reduction
In order to test the idea that salt restriction would lower blood 
pressure, Sacks et al. (41) performed a thorough study in normo-
tensive subjects of the effect of salt restriction and found decreases 
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of average systolic blood pressure between 2.2 and 5.9 mmHg and 
decreases of average diastolic blood pressure between 1.0 and 
2.9 mmHg.
SHOULD SALT ReSTRiCTiON Be 
ADMiNiSTeReD TO HYPeRTeNSive 
PATieNTS?
In some non-Caucasian ethnic groups, the so-called “low renin-
hypertension” is an important, and sometimes overlooked, 
cause. This needs to be managed for each individual as there may 
be a logical decision to impose a low salt diet. The same result 
of the individual consultation process may be implemented in 
patients whose hypertension has a definable cause such as kidney 
disease. This situation highlights the need for people’s health or 
health problems to be supervised for them as individuals. The 
great Nobel Prize laureate, Feynman (42), deprecates politicians 
making generally applicable policies based on only one side 
of a scientific argument and not necessarily applicable to all 
individuals.
The commonist underlying metabolic abnormality in hyper-
tensive patients is insulin resistance or “metabolic syndrome,” 
frequently accompanied by obesity. In these patients, high blood 
pressure responds satisfactorily to weight reduction (43). It can 
safely be assumed that weight reduction, particularly carbo-
hydrate intake reduction, is also an effective treatment for the 
insulin resistance. There is evidence to suggest that BP is lowered 
in hypertension by Mediterranean and Nordic diets (44); so it will 
be extremely difficult to separate the effect of low salt from all the 
other ingredients of diet that may lower BP.
It is unusual for salt restriction to be necessary in the treatment 
of clinical hypertension. In the typical patient in Europe, the key 
to clinical management is the relationship between sodium and 
the renin–angiotensin system (45, 46). In these patients, who are 
the majority, suppression of the activity of the renin–angiotensin 
system by angiotensin-converting enzyme (ACE), or angiotensin 
II receptor antagonism, is effective in both controlling the BP 
and reducing the complications of hypertension. Diabetes also 
occurs in the insulin resistance triad of obesity/hypertension/
diabetes, but salt restriction makes diabetes worse (2). It is illogi-
cal for such patients to also indulge in salt restriction, unless they 
have kidney disease, so doctors do not recommend it. Perhaps 
salt restriction not supervised for the individual by his doctor 
contributes to the increasing prevalence of hyponatremia in 
patients with heart failure, the commonist end condition of 
uncontrolled hypertension?
wHiCH POPULATiONS SHOULD ReCeive 
HiGH-SALT AND wHiCH LOw-SALT 
DieTS?
 1. Patients with low exchangeable sodium values should have a 
high rather than a low-salt diet, while patients with specified 
types of cardiovascular disease such as low-renin hyperten-
sion should be considered for low-salt diet.
 2. The consequence of low salt in elderly and chronic sick can 
reasonably be postulated to cause increased severity of illness. 
A possible additional hypothesis is that low-salt diet in the not 
obviously ill person may induce hyponatremic illness.
 3. Of particular concern in addition is the ingestion of inadequate 
salt intake without adequate investigation in hot climates and 
patients with severe cardiovascular disease and cancer.
CONCLUSiON
The increasing prevalence of hyponatremia is a worrying devel-
opment and an increasing burden for health services. Whether 
this increasing prevalence is related in any way to the increasing 
adoption by the population of low salt diet cannot be proved, only 
postulated. The relationship between salt intake and hyperten-
sion also cannot be proved, only postulated, because there is 
contrary evidence and a continuing debate. Low-salt diet is only 
recommended as treatment of hypertension in single individuals 
following thorough renal and endocrinological investigations. 
The possibility that universal low salt ingestion by the population 
might perhaps contribute to the prevalence of hyponatremia 
should be sufficient reason for such universal ingestion to be 
replaced by individual care of individuals by the individual’s 
doctor.
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